The molecular genetics of Marfan syndrome and related disorders
- PMID: 16571647
- PMCID: PMC2563177
- DOI: 10.1136/jmg.2005.039669
The molecular genetics of Marfan syndrome and related disorders
Abstract
Marfan syndrome (MFS), a relatively common autosomal dominant hereditary disorder of connective tissue with prominent manifestations in the skeletal, ocular, and cardiovascular systems, is caused by mutations in the gene for fibrillin-1 (FBN1). The leading cause of premature death in untreated individuals with MFS is acute aortic dissection, which often follows a period of progressive dilatation of the ascending aorta. Recent research on the molecular physiology of fibrillin and the pathophysiology of MFS and related disorders has changed our understanding of this disorder by demonstrating changes in growth factor signalling and in matrix-cell interactions. The purpose of this review is to provide a comprehensive overview of recent advances in the molecular biology of fibrillin and fibrillin-rich microfibrils. Mutations in FBN1 and other genes found in MFS and related disorders will be discussed, and novel concepts concerning the complex and multiple mechanisms of the pathogenesis of MFS will be explained.
Conflict of interest statement
Competing interests: none declared
References
-
- Robinson P N, Godfrey M.Marfan syndrome: a primer for clinicians and scientists. New York: Kluwer Academic/Plenum, 2004
-
- Pyeritz R E. The Marfan syndrome. Annu Rev Med 200051481–510. - PubMed
-
- Corson G M, Charbonneau N L, Keene D R, Sakai L Y. Differential expression of fibrillin‐3 adds to microfibril variety in human and avian, but not rodent, connective tissues. Genomics 200483(3)461–472. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical